Thermo Fisher Scientific, Inc. (TMO)
464.37
-11.52
(-2.42%)
USD |
NYSE |
Mar 13, 16:00
463.00
-1.37
(-0.30%)
After-Hours: 20:00
Thermo Fisher Scientific Enterprise Value : 203.38B for March 13, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Sotera Health Co. | 5.742B |
| Danaher Corp. | 147.55B |
| FONAR Corp. | 88.44M |
| Eli Lilly & Co. | 916.27B |
| Interpace Biosciences, Inc. | 49.03M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 1.97B |
| Revenue (Quarterly) | 12.22B |
| Total Expenses (Quarterly) | 10.25B |
| EPS Diluted (Quarterly) | 5.210 |
| Gross Profit Margin (Quarterly) | 38.29% |
| Profit Margin (Quarterly) | 16.13% |
| Earnings Yield | 3.82% |
| Operating Earnings Yield | 4.78% |
| Normalized Earnings Yield | 3.937 |